Effect of ropinirole on visuo-motor test in newly diagnosed Parkinson's disease patients

Acta Neurologica Scandinavica
S BadarnyS Hocherman

Abstract

The aim of this study was to assess the sensitivity of the visuo-motor test (VMT) compared with the Unified Parkinson's Disease Rating Scale (UPDRS) in newly diagnosed Parkinson's disease (PD) patients. VMT and UPDRS were carried out in 20 patients before treatment onset, 2 weeks after treatment with ropinirole 1.5 mg/day and 2 weeks following increasing the dose of ropinirole to 3.0 mg/day. Improvement in clinical status was seen in all patients, with a mean UPDRS reduction of 16.6% following treatment with ropinirole 1.5 mg/day, and 38.9% reduction in UPDRS observed with ropinirole 3.0 mg/day. Initial improvement was not correlated with severity of PD, although further improvement with ropinirole 3.0 mg/day correlated linearly with patient's baseline UPDRS. Improvement in the ability to control the direction of the moving hand during tracing is expressed by the reduction of VMT variables following treatment. Mean VMT variables were 36.2% at baseline, 34.0% with ropinirole 1.5 mg/day and 31.7% with ropinirole 3.0 mg/day. Although changes in VMT variables were less uniform across patients, on average, it did correlate with patients UPDRS. We suggest that VMT can be useful in the assessment of treatment effect on high-level moto...Continue Reading

References

Dec 1, 1992·Brain : a Journal of Neurology·A M OwenT W Robbins
Jan 1, 1988·Movement Disorders : Official Journal of the Movement Disorder Society·R G Brown, C D Marsden
Jan 1, 1994·Neurology·S Hocherman, J Aharon-Peretz
Sep 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·J S Schneider, A Pope-Coleman
Feb 25, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·M D Kuzel
Mar 17, 2000·Brain Research. Brain Research Reviews·F A Middleton, P L Strick
Aug 12, 2000·Perceptual and Motor Skills·S Hocherman, H Levy
May 3, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A SchragUNKNOWN Ropinirole Study Group
Jul 20, 2002·Progress in Neurobiology·André Nieoullon
Sep 13, 2002·Acta Neurologica Scandinavica·A D KorczynC H Adler
Dec 5, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K MarekJ Seibyl
Dec 14, 2002·Lancet·C E Clarke, M Guttman
Apr 12, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mahyar EtminanAli Samii
Jul 3, 2003·Annals of Neurology·Alan L WhoneUNKNOWN REAL-PET Study Group
Jul 30, 2003·Archives of Internal Medicine·Nicole Simpkins, Joseph Jankovic
Aug 30, 2003·Journal of Neural Transmission. Supplementum·M GerlachP Riederer
Oct 31, 2003·Expert Opinion on Investigational Drugs·Ron Tintner, Joseph Jankovic
Aug 25, 2004·Brain Research. Cognitive Brain Research·Shraga HochermanMiguel Schwartz
Jul 2, 2008·Parkinsonism & Related Disorders·S HochermanS Honigman
May 1, 1998·Trends in Cognitive Sciences·D P Carey

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.